Uni-Bio Science Group Ltd
HKEX:690
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
0.041
0.097
|
Price Target |
|
We'll email you a reminder when the closing price reaches HKD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
Abbvie Inc
NYSE:ABBV
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Realty Income Corp
NYSE:O
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one Uni-Bio Science Group Ltd stock under the Base Case scenario is 0.099 HKD. Compared to the current market price of 0.077 HKD, Uni-Bio Science Group Ltd is Undervalued by 22%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Uni-Bio Science Group Ltd
Run backtest to discover the historical profit from buying and selling Uni-Bio Science Group Ltd based on its intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Price Target |
Loading
|
Revenue Forecast |
|
Operating Income Forecast |
|
Earnings Forecast |
|
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Uni-Bio Science Group Ltd
Balance Sheet Decomposition
Uni-Bio Science Group Ltd
Current Assets | 296.4m |
Cash & Short-Term Investments | 164.9m |
Receivables | 91.3m |
Other Current Assets | 40.2m |
Non-Current Assets | 190.7m |
PP&E | 130.4m |
Intangibles | 39.2m |
Other Non-Current Assets | 21.2m |
Current Liabilities | 118.3m |
Accounts Payable | 57.1m |
Other Current Liabilities | 61.2m |
Non-Current Liabilities | 56.1m |
Long-Term Debt | 56.1m |
Earnings Waterfall
Uni-Bio Science Group Ltd
Revenue
|
508.4m
HKD
|
Cost of Revenue
|
-83.8m
HKD
|
Gross Profit
|
424.6m
HKD
|
Operating Expenses
|
-319.9m
HKD
|
Operating Income
|
104.7m
HKD
|
Other Expenses
|
-5.8m
HKD
|
Net Income
|
98.9m
HKD
|
Free Cash Flow Analysis
Uni-Bio Science Group Ltd
HKD | |
Free Cash Flow | HKD |
Profitability Score
Profitability Due Diligence
Uni-Bio Science Group Ltd's profitability score is 64/100. The higher the profitability score, the more profitable the company is.
Score
Uni-Bio Science Group Ltd's profitability score is 64/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Uni-Bio Science Group Ltd's solvency score is 73/100. The higher the solvency score, the more solvent the company is.
Score
Uni-Bio Science Group Ltd's solvency score is 73/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Uni-Bio Science Group Ltd
Shareholder Yield
Current shareholder yield for Uni-Bio Science Group Ltd is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Price
Uni-Bio Science Group Ltd
Average Annual Return | -21.93% |
Standard Deviation of Annual Returns | 7.33% |
Max Drawdown | -82% |
Market Capitalization | 468m HKD |
Shares Outstanding | 6 278 768 147 |
Percentage of Shares Shorted |
N/A
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Uni-Bio Science Group Ltd. is an investment holding company with interests in pharmaceutical research and development. The company employs 326 full-time employees The company went IPO on 2001-11-12. The firm operates through four segments. In-house Chemical Pharmaceutical Products segment is engaged in the manufacture and sales of in-house chemical pharmaceutical products. Its chemical pharmaceutical products include Pinapu, among others. In-house Biological Pharmaceutical Products segment is engaged in the manufacture and sales of in-house biological pharmaceutical products. Its biological pharmaceutical products include GeneTime and GeneSoft, among others. In-house Biological Pipeline segment is engaged in the industrialization of in-house biological pipeline. Its biological pipeline products include Uni-E4 and Uni-PTH, among others. Third-party Pharmaceutical Products segment is engaged in the sales of third-party pharmaceutical products.
Contact
IPO
Employees
Officers
The intrinsic value of one Uni-Bio Science Group Ltd stock under the Base Case scenario is 0.099 HKD.
Compared to the current market price of 0.077 HKD, Uni-Bio Science Group Ltd is Undervalued by 22%.